- Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pillPlus, news about Merck, MultiValent Biotherapies, Alvotech, enGene, Mirum, and Adaptive Biotechnologies. 💸 Eli Lilly acquires another pain biotech: The Indianapolis pharma giant has made its 11t…Endpoints · 1mo ago↗ source
- UCSF spinout Kopra Bio raises $9.1M to test virus therapy in brain cancerGlioblastoma is notoriously good at evading the immune system, making it particularly resistant to immunotherapy, but now researchers may have found a clever workaround. Scientists at the Universi…Endpoints · 1mo ago↗ source
- CMS seeks to close Medicare negotiation 'loophole'CMS has proposed a policy change that clarifies its stance on how products are grouped together for Medicare negotiations. Under the Inflation Reduction Act, biologics become eligible for Medicar…